HIV 1 News and Research

RSS

Mpox incidence across rural and urban areas in the US

Researchers explored the differences in rural and urban mpox incidence in the United States (US).

31 May 2023

New method may help identify the essential ingredients for making an effective HIV vaccine

Since it was identified in 1984 as the cause of Acquired Immune Deficiency Syndrome (AIDS), the human immunodeficiency virus (HIV) has infected more than 80 million people and been responsible for some 40 million deaths worldwide, according to the World Health Organization (WHO).

30 May 2023

Novel technology enhances potency and breadth of vaccine-induced responses through antigen presentation

Novel EABR technology enhances potency and breadth of vaccine-induced responses through antigen presentation.

30 May 2023

The potential clinical benefit of the Multabody platform as a therapeutic for SARS-CoV-2

The potential clinical benefit of the Multabody platform as a therapeutic for SARS-CoV-2.

26 May 2023

Antiviral drugs may be a new treatment strategy in the fight against Candida auris

Antiviral drugs can make antifungals work again.

25 May 2023

Nonhuman primate study helps explain how stem cell transplantation can kill HIV virus

New animal research is helping explain why at least five people have become HIV-free after receiving a stem cell transplant.

25 May 2023

Immune cells targeting core protein play an important role in early immune defense against COVID-19

LMU immunologists have studied the early immune response to acute SARS-CoV-2 infection and show how vaccines could be improved in future.

25 May 2023

First-in-human nanoparticle HIV vaccine induces broad and publicly targeted helper T cell responses

Researchers from Fred Hutchinson Cancer Center in Seattle, Scripps Research in La Jolla, California, IAVI and other collaborating institutions have characterized robust T-cell responses in volunteers participating in the IAVI G001 Phase 1 clinical trial to test the safety and immune response of a self-assembling nanoparticle HIV vaccine.

25 May 2023

The first thousand days of development

Study provides a bird's-eye view of the significant moments of the first thousand days of life.

25 May 2023

Unstable housing fuels risky behaviors among US high school students, CDC study warns

Youths experiencing unstable housing face elevated health risks, including poor physical and mental health outcomes. Disproportionate burden is observed among youths of color and sexual minority youths.

24 May 2023

CDC reports on its Mpox response

Research paper provides an overview of the U.S. monkeypox outbreak, highlighting the rapid response, vaccination efforts, and racial disparities in cases. Ongoing surveillance, vaccination, and communication are emphasized as crucial for future prevention.

24 May 2023

Looking at cancer drugs to help put the brakes on classic indicators of aging

Antiretroviral cocktails can make human immunodeficiency virus, or HIV, undetectable and untransmittable, but both the virus and its treatment can also accelerate aging of bone and muscle.

24 May 2023

The antimicrobial potential of nanoparticles

Nanoparticles have widely been used as advanced tools for the diagnosis, prevention, and treatment of infectious diseases.

23 May 2023

Revolutionizing Schizophrenia Research with the Queensland Brain Institute

To commemorate World Schizophrenia Awareness Day, we spoke to three researchers from the Queensland Brain Institiute about their research, and why it is so important to raise awareness around Schizophrenia

23 May 2023

$11.6 million NIDA grant supports the study of cannabis effects on HIV-infected brains

Weill Cornell Medicine has been awarded a five-year, $11.6 million grant from the National Institute on Drug Abuse of the National Institutes of Health to study the effects cannabis, including marijuana and compounds derived from it, may have on the brains of those living with HIV.

23 May 2023

Real-world assessment of JYNNEOS vaccine effectiveness during the 2022 mpox outbreak in the US

A recent study published in Morbidity and Mortality Weekly Report estimated the efficacy of the JYNNEOS vaccine against mpox.

22 May 2023

Novel gene-editing strategy harnesses an unusual protective ability to eliminate HIV-1 infection

Genetic alterations that give rise to a rare, fatal disorder known as MOGS-CDG paradoxically also protect cells against infection by viruses.

19 May 2023

Shortages of health workers strongly associated with higher death rates

Shortages of health workers such as doctors, nurses and midwifery staff are strongly associated with higher death rates, especially for certain diseases such as neglected tropical diseases and malaria, pregnancy and birth complications, diabetes and kidney diseases, finds an analysis of 172 countries and territories, published by The BMJ today.

12 May 2023

Targeting the hemoglobin problem in sickle cell disease using a new drug

A class of drugs used for their ability to stop tumor cells from dividing is now under study for their potential to reduce the pain and damage caused by sickle cell disease, investigators report.

11 May 2023

Medicines for All Institute at VCU receives $18.7 million grant to improve access to medicines

The Medicines for All Institute at Virginia Commonwealth University will work on 14 new global health projects and expand its capabilities to improve access to medicines around the world thanks to an $18.7 million grant from the Bill & Melinda Gates Foundation.

11 May 2023

HIV 1 News and Research

Mpox incidence across rural and urban areas in the US

New method may help identify the essential ingredients for making an effective HIV vaccine

Novel technology enhances potency and breadth of vaccine-induced responses through antigen presentation

The potential clinical benefit of the Multabody platform as a therapeutic for SARS-CoV-2

Antiviral drugs may be a new treatment strategy in the fight against Candida auris

Nonhuman primate study helps explain how stem cell transplantation can kill HIV virus

Immune cells targeting core protein play an important role in early immune defense against COVID-19

First-in-human nanoparticle HIV vaccine induces broad and publicly targeted helper T cell responses

The first thousand days of development

Unstable housing fuels risky behaviors among US high school students, CDC study warns

CDC reports on its Mpox response

Looking at cancer drugs to help put the brakes on classic indicators of aging

The antimicrobial potential of nanoparticles

Revolutionizing Schizophrenia Research with the Queensland Brain Institute

$11.6 million NIDA grant supports the study of cannabis effects on HIV-infected brains

Real-world assessment of JYNNEOS vaccine effectiveness during the 2022 mpox outbreak in the US

Novel gene-editing strategy harnesses an unusual protective ability to eliminate HIV-1 infection

Shortages of health workers strongly associated with higher death rates

Targeting the hemoglobin problem in sickle cell disease using a new drug

Medicines for All Institute at VCU receives $18.7 million grant to improve access to medicines

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News